Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study-Reference-Cited by-同舟云学术

Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study

Published:2022-10 Issue: Volume:52 Page:101562
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Liu Yu,Wang Ying,Wang Yuxiang,Xie Yu,Cui Yanfen,Feng Senwen,Yao Mengxia,Qiu Bingjiang,Shen Wenqian,Chen Dong,Du Guoqing,Chen Xin,Liu Zaiyi,Li Zhenhui,Yang Xiaotang,Liang Changhong,Wu Lei

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor-2-positive breast cancer;Zhao;Int J Cancer,2018

2. HER2-positive breast cancer;Loibl;Lancet,2017

3. Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers;Pusztai;Lancet Oncol,2019

4. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis;Spring;Clin Cancer Res,2020

5. Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment;Fatayer;Eur J Surg Oncol,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data;The Breast;2024-10

2. Multitask machine learning-based tumor-associated collagen signatures predict peritoneal recurrence and disease-free survival in gastric cancer;Gastric Cancer;2024-09-14

3. Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer;npj Precision Oncology;2024-09-05

4. Predicting Pathological Characteristics of HER2-Positive Breast Cancer from Ultrasound Images: a Deep Ensemble Approach;Journal of Imaging Informatics in Medicine;2024-08-26

5. A glimpse into the future: Integrating artificial intelligence for precision HER2‐positive breast cancer management;iMetaOmics;2024-08-02